Shah Preetam 4
4 · Cidara Therapeutics, Inc. · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Award
Common Stock
2023-03-27+90,000→ 238,141 total - Award
Employee Stock Option (right to buy)
2023-03-27+180,000→ 180,000 totalExercise: $1.01Exp: 2033-03-26→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.